As of today (2024-04-23), Cormedix's share price is $5.46. Cormedix's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.28. Hence, Cormedix's Price to Tangible Book Ratio of today is 4.28.
The historical rank and industry rank for Cormedix's Price-to-Tangible-Book or its related term are showing as below:
CRMD'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.15 Med: 4.23 Max: 28.41
Current: 4.27
During the past 13 years, Cormedix's highest Price to Tangible Book Ratio was 28.41. The lowest was 2.15. And the median was 4.23.
CRMD's Price-to-Tangible-Book is ranked worse than 66.01% of 1221
companies
in the Biotechnology industry
Industry Median: 2.67
vs CRMD: 4.27
A closely related ratio is called PB Ratio. As of today, Cormedix's share price is $5.46. Cormedix's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.28. Hence, Cormedix's P/B Ratio of today is 4.28.
Cormedix Price-to-Tangible-Book Historical Data
The historical data trend for Cormedix's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Cormedix's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cormedix Price-to-Tangible-Book Distribution
For the Biotechnology industry and Healthcare sector, Cormedix's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Cormedix's Price-to-Tangible-Book falls into.
Cormedix Price-to-Tangible-Book Calculation
Cormedix's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Cormedix Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Cormedix's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is to develop its lead product candidate, DefenCath, for potential commercialization in the United States (U.S.) and other key markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRMD has been successfully added to your 